Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 26.57
+0.39 (1.49%)
Mar 10, 2026, 11:15 AM CST
Guobang Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 1,312 | 1,909 | 2,094 | 1,974 | 893.01 | 1,235 | Upgrade
|
| Trading Asset Securities | 896.34 | 617.66 | 465.99 | 824.56 | 1,258 | 0.03 | Upgrade
|
| Cash & Short-Term Investments | 2,208 | 2,527 | 2,560 | 2,799 | 2,151 | 1,235 | Upgrade
|
| Cash Growth | 2.21% | -1.29% | -8.52% | 30.09% | 74.24% | -2.38% | Upgrade
|
| Accounts Receivable | 1,424 | 1,332 | 964.92 | 775.34 | 571.5 | 544.51 | Upgrade
|
| Other Receivables | 16.59 | 17.97 | 17.22 | 21.07 | 45.03 | 30.83 | Upgrade
|
| Receivables | 1,441 | 1,350 | 982.14 | 796.41 | 616.53 | 575.34 | Upgrade
|
| Inventory | 1,623 | 1,363 | 1,369 | 1,409 | 1,309 | 989.55 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.7 | - | Upgrade
|
| Other Current Assets | 479.55 | 634.05 | 532.31 | 125.15 | 489.48 | 71.64 | Upgrade
|
| Total Current Assets | 5,752 | 5,874 | 5,443 | 5,129 | 4,567 | 2,871 | Upgrade
|
| Property, Plant & Equipment | 4,272 | 4,344 | 4,330 | 3,284 | 2,622 | 2,152 | Upgrade
|
| Long-Term Investments | 115.81 | 112.57 | 121.13 | 101.37 | 17.11 | 18.67 | Upgrade
|
| Goodwill | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Other Intangible Assets | 344.59 | 350.83 | 358.85 | 370.5 | 272.26 | 266.71 | Upgrade
|
| Long-Term Deferred Tax Assets | 10.8 | 8.96 | 7.78 | 6.59 | 19.02 | 12.01 | Upgrade
|
| Long-Term Deferred Charges | 7.1 | 7.45 | 8.02 | 9.26 | 2.6 | 3.37 | Upgrade
|
| Other Long-Term Assets | 76.59 | 82.64 | 92.64 | 142.61 | 12.79 | 184.52 | Upgrade
|
| Total Assets | 10,579 | 10,780 | 10,362 | 9,043 | 7,513 | 5,509 | Upgrade
|
| Accounts Payable | 1,118 | 1,704 | 1,715 | 974.35 | 789.71 | 1,096 | Upgrade
|
| Accrued Expenses | 77.52 | 125.97 | 97.06 | 107.06 | 100.47 | 86.68 | Upgrade
|
| Short-Term Debt | 441.42 | 181.23 | 488.79 | 664.28 | 168.88 | 518.12 | Upgrade
|
| Current Portion of Long-Term Debt | 37.98 | 452.17 | 28.88 | - | - | 150.25 | Upgrade
|
| Current Income Taxes Payable | 49.93 | 22.47 | 18.44 | 4.26 | 30.24 | 23.57 | Upgrade
|
| Current Unearned Revenue | 32.87 | 39.93 | 55.85 | 52.79 | 30.68 | 42.71 | Upgrade
|
| Other Current Liabilities | 38.17 | 32.34 | 45.99 | 59.64 | 33.53 | 55.39 | Upgrade
|
| Total Current Liabilities | 1,796 | 2,558 | 2,450 | 1,862 | 1,154 | 1,972 | Upgrade
|
| Long-Term Debt | 478.71 | 146.72 | 451.7 | - | - | 251 | Upgrade
|
| Long-Term Unearned Revenue | 23.44 | 16.67 | 11.8 | 14.27 | 9.71 | 8.27 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5.87 | 7.2 | 11.32 | 11.93 | 4.16 | 2.69 | Upgrade
|
| Total Liabilities | 2,304 | 2,728 | 2,924 | 1,889 | 1,167 | 2,234 | Upgrade
|
| Common Stock | 558.82 | 558.82 | 558.82 | 558.82 | 558.82 | 475 | Upgrade
|
| Additional Paid-In Capital | 3,608 | 3,609 | 3,607 | 3,607 | 3,607 | 1,047 | Upgrade
|
| Retained Earnings | 4,216 | 3,881 | 3,266 | 2,989 | 2,180 | 1,753 | Upgrade
|
| Treasury Stock | -111.13 | -1.48 | - | - | - | - | Upgrade
|
| Total Common Equity | 8,272 | 8,047 | 7,432 | 7,155 | 6,346 | 3,275 | Upgrade
|
| Minority Interest | 3.63 | 4.72 | 5.15 | -0.65 | -0.39 | -0.58 | Upgrade
|
| Shareholders' Equity | 8,275 | 8,052 | 7,437 | 7,155 | 6,346 | 3,274 | Upgrade
|
| Total Liabilities & Equity | 10,579 | 10,780 | 10,362 | 9,043 | 7,513 | 5,509 | Upgrade
|
| Total Debt | 958.11 | 780.12 | 969.37 | 664.28 | 168.88 | 919.37 | Upgrade
|
| Net Cash (Debt) | 1,250 | 1,747 | 1,591 | 2,134 | 1,982 | 315.27 | Upgrade
|
| Net Cash Growth | -0.10% | 9.81% | -25.46% | 7.66% | 528.79% | 12.17% | Upgrade
|
| Net Cash Per Share | 2.25 | 3.13 | 2.86 | 3.82 | 3.87 | 0.67 | Upgrade
|
| Filing Date Shares Outstanding | 550.61 | 558.37 | 555.51 | 558.82 | 558.82 | 475 | Upgrade
|
| Total Common Shares Outstanding | 550.61 | 558.74 | 558.82 | 558.82 | 558.82 | 475 | Upgrade
|
| Working Capital | 3,956 | 3,317 | 2,994 | 3,267 | 3,414 | 898.7 | Upgrade
|
| Book Value Per Share | 15.02 | 14.40 | 13.30 | 12.80 | 11.36 | 6.89 | Upgrade
|
| Tangible Book Value | 7,927 | 7,696 | 7,073 | 6,785 | 6,074 | 3,008 | Upgrade
|
| Tangible Book Value Per Share | 14.40 | 13.77 | 12.66 | 12.14 | 10.87 | 6.33 | Upgrade
|
| Buildings | - | 1,812 | 1,706 | 1,025 | 810.75 | 717 | Upgrade
|
| Machinery | - | 3,980 | 3,372 | 2,487 | 1,933 | 1,646 | Upgrade
|
| Construction In Progress | - | 255.26 | 636.65 | 874.85 | 827.46 | 571.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.